Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types
These findings demonstrate that ZBTB11 is associated with multiple tumor types and disease prognosis. ZBTB11 may represent a potential key biomarker and therapeutic target in cancers.
Authors
- Xueting Deng (ORCID: https://orcid.org/0000-0002-9657-5030)
- Qiuyan Zhang
- Pu Chen (ORCID: https://orcid.org/0000-0002-3628-3511)
- Lin Miao (ORCID: https://orcid.org/0000-0003-0248-2544)
- Xiuhua Zhang
- Peiyi Xu
- Jing Zhai (ORCID: https://orcid.org/0009-0002-4679-0039)
Institutions
- Second Affiliated Hospital of Nanjing Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1007/s12672-024-01697-4
- Citations
- 2
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- National Natural Science Foundation of China